Immuneering CorporationImmuneering CorporationImmuneering Corporation

Immuneering Corporation

No trades
See on Supercharts

Price target

13.290.00 0.00%
The 7 analysts offering 1 year price forecasts for IMRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to IMRX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

IMRX EPS for the last quarter is −0.52 USD despite the estimation of −0.46 USD. In the next quarter EPS is expected to reach −0.50 USD. Track more of Immuneering Corporation financials and stay on top of what is up with the company.
According to analysts, IMRX price target is 13.29 USD with a max estimate of 25.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch Immuneering Corporation stock price chart and keep track of the current situation with IMRX news and stock market news.
We've gathered opinions of 8 analysts rating IMRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.